Published in EMBO J on March 31, 2005
HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature (2008) 14.17
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol (2009) 7.11
A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev (2007) 5.83
RNA processing and its regulation: global insights into biological networks. Nat Rev Genet (2010) 5.34
Unusual intron conservation near tissue-regulated exons found by splicing microarrays. PLoS Comput Biol (2006) 4.63
Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data. Nat Biotechnol (2011) 3.18
Discovery and analysis of evolutionarily conserved intronic splicing regulatory elements. PLoS Genet (2007) 2.60
HITS-CLIP: panoramic views of protein-RNA regulation in living cells. Wiley Interdiscip Rev RNA (2010) 2.59
HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J (2005) 2.20
Understanding splicing regulation through RNA splicing maps. Trends Genet (2011) 2.12
Analysis of CLIP and iCLIP methods for nucleotide-resolution studies of protein-RNA interactions. Genome Biol (2012) 1.85
Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. Genes Dev (2012) 1.70
Regulation of alternative splicing by the core spliceosomal machinery. Genes Dev (2011) 1.60
A comprehensive computational characterization of conserved mammalian intronic sequences reveals conserved motifs associated with constitutive and alternative splicing. Genome Res (2007) 1.58
Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res (2012) 1.42
Autoregulation of Fox protein expression to produce dominant negative splicing factors. RNA (2009) 1.34
An insight into the sialome of Glossina morsitans morsitans. BMC Genomics (2010) 1.34
RNA protein interaction in neurons. Annu Rev Neurosci (2013) 1.31
Exon selection in alpha-tropomyosin mRNA is regulated by the antagonistic action of RBM4 and PTB. Mol Cell Biol (2005) 1.28
Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proc Natl Acad Sci U S A (2009) 1.27
Evolution of Nova-dependent splicing regulation in the brain. PLoS Genet (2007) 1.23
A consensus CaMK IV-responsive RNA sequence mediates regulation of alternative exons in neurons. RNA (2005) 1.19
Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev (2008) 1.18
Networking in a global world: establishing functional connections between neural splicing regulators and their target transcripts. RNA (2011) 1.14
Tissue-specific splicing regulator Fox-1 induces exon skipping by interfering E complex formation on the downstream intron of human F1gamma gene. Nucleic Acids Res (2007) 1.11
ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet (2013) 1.07
Prediction of clustered RNA-binding protein motif sites in the mammalian genome. Nucleic Acids Res (2013) 1.05
The Neuronal Splicing Factor Nova Co-Localizes with Target RNAs in the Dendrite. Front Neural Circuits (2010) 1.05
Alternative splicing: functional diversity among voltage-gated calcium channels and behavioral consequences. Biochim Biophys Acta (2012) 1.04
PIPE-CLIP: a comprehensive online tool for CLIP-seq data analysis. Genome Biol (2014) 1.03
NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. Elife (2013) 1.03
The function of spliceosome components in open mitosis. Nucleus (2010) 1.01
Protein-RNA and protein-protein recognition by dual KH1/2 domains of the neuronal splicing factor Nova-1. Structure (2011) 1.01
The CUGBP2 splicing factor regulates an ensemble of branchpoints from perimeter binding sites with implications for autoregulation. PLoS Genet (2009) 0.99
Promotion of exon 6 inclusion in HuD pre-mRNA by Hu protein family members. Nucleic Acids Res (2010) 0.95
MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma. PLoS One (2014) 0.94
Characterization of sequences and mechanisms through which ISE/ISS-3 regulates FGFR2 splicing. Nucleic Acids Res (2006) 0.93
The neurogenetics of alternative splicing. Nat Rev Neurosci (2016) 0.91
Ab initio identification of functionally interacting pairs of cis-regulatory elements. Genome Res (2008) 0.88
An integrated regulatory network reveals pervasive cross-regulation among transcription and splicing factors. PLoS Comput Biol (2012) 0.88
ADAM15 gene structure and differential alternative exon use in human tissues. BMC Mol Biol (2007) 0.84
Nova1 is a master regulator of alternative splicing in pancreatic beta cells. Nucleic Acids Res (2014) 0.83
TOX4 and NOVA1 proteins are partners of the LEDGF PWWP domain and affect HIV-1 replication. PLoS One (2013) 0.82
Disabled-1 alternative splicing in human fetal retina and neural tumors. PLoS One (2011) 0.81
The bromodomain-containing gene BRD2 is regulated at transcription, splicing, and translation levels. J Cell Biochem (2011) 0.80
The PUF binding landscape in metazoan germ cells. RNA (2016) 0.80
RNA regulation in neurologic disease and cancer. Cancer Res Treat (2010) 0.80
Dynamic expression pattern of neuro-oncological ventral antigen 1 (Nova1) in the rat brain after focal cerebral ischemia/reperfusion insults. J Histochem Cytochem (2012) 0.78
Evolutionarily conserved autoregulation of alternative pre-mRNA splicing by ribosomal protein L10a. Nucleic Acids Res (2016) 0.77
NOVA2-mediated RNA regulation is required for axonal pathfinding during development. Elife (2016) 0.76
The salmonid myostatin gene family: a novel model for investigating mechanisms that influence duplicate gene fate. BMC Evol Biol (2012) 0.75
The determinants of alternative RNA splicing in human cells. Mol Genet Genomics (2017) 0.75
Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem (2003) 21.11
Predictive identification of exonic splicing enhancers in human genes. Science (2002) 16.86
Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science (2003) 16.80
Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet (2002) 16.29
ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res (2003) 12.81
PEST sequences and regulation by proteolysis. Trends Biochem Sci (1996) 8.90
CLIP identifies Nova-regulated RNA networks in the brain. Science (2003) 8.88
Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell (1992) 7.90
Protein kinase recognition sequence motifs. Trends Biochem Sci (1990) 7.49
Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res (2002) 6.71
Paraneoplastic syndromes involving the nervous system. N Engl J Med (2003) 5.46
HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell (1991) 4.61
Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron (2000) 4.24
Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell (2000) 3.59
Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol Cell (2001) 3.34
Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J Biol Chem (1987) 3.19
Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature (1996) 3.12
The human genome: organization and evolutionary history. Annu Rev Genet (1995) 3.11
Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem J (2003) 2.89
Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron (1993) 2.81
The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol Cell Biol (1997) 2.69
Tissue-specific splicing in vivo of the beta-tropomyosin gene: dependence on an RNA secondary structure. Science (1991) 2.60
Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J (1999) 2.34
Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature (1998) 2.26
The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci U S A (1998) 2.22
The protein kinase Clk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing. Mol Cell Biol (1999) 2.09
The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci (1996) 2.03
Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol Cell Biol (2003) 2.00
The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. Proc Natl Acad Sci U S A (2000) 1.92
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature (2008) 14.17
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature (2009) 14.07
De novo gene disruptions in children on the autistic spectrum. Neuron (2012) 9.69
The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res (2007) 9.32
CLIP identifies Nova-regulated RNA networks in the brain. Science (2003) 8.88
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell (2011) 8.46
An RNA map predicting Nova-dependent splicing regulation. Nature (2006) 7.63
Nova regulates brain-specific splicing to shape the synapse. Nat Genet (2005) 6.58
CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods (2005) 6.26
RNA processing and its regulation: global insights into biological networks. Nat Rev Genet (2010) 5.34
Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data. Nat Biotechnol (2011) 3.18
An alternative mode of microRNA target recognition. Nat Struct Mol Biol (2012) 2.77
Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls. Science (2010) 2.69
Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol Cell (2012) 2.54
Splicing regulation in neurologic disease. Neuron (2006) 2.46
Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev (2005) 2.38
Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J Neurosci (2004) 2.20
Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling. Neuron (2010) 2.08
RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr Opin Neurobiol (2006) 2.08
Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol Cell Biol (2003) 2.00
EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J (2012) 1.91
CLIP: crosslinking and immunoprecipitation of in vivo RNA targets of RNA-binding proteins. Methods Mol Biol (2008) 1.79
Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron (2012) 1.78
Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. Genes Dev (2012) 1.70
Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer (2004) 1.55
Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs. Hum Mol Genet (2009) 1.53
Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction. Nat Struct Mol Biol (2011) 1.38
The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development. EMBO J (2002) 1.38
Common molecular pathways mediate long-term potentiation of synaptic excitation and slow synaptic inhibition. Cell (2005) 1.36
A mouse model of the human Fragile X syndrome I304N mutation. PLoS Genet (2009) 1.36
Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol (2005) 1.35
The let-7 microRNA target gene, Mlin41/Trim71 is required for mouse embryonic survival and neural tube closure. Cell Cycle (2008) 1.32
Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron (2012) 1.27
Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proc Natl Acad Sci U S A (2009) 1.27
Evolution of Nova-dependent splicing regulation in the brain. PLoS Genet (2007) 1.23
Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells. J Biol Chem (2004) 1.22
The fragile X mental retardation protein, FMRP, recognizes G-quartets. Ment Retard Dev Disabil Res Rev (2004) 1.14
IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. J Immunol (2006) 1.13
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood (2006) 1.13
Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol (2004) 1.08
Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells. J Clin Invest (2009) 1.08
Prediction of clustered RNA-binding protein motif sites in the mammalian genome. Nucleic Acids Res (2013) 1.05
The Neuronal Splicing Factor Nova Co-Localizes with Target RNAs in the Dendrite. Front Neural Circuits (2010) 1.05
NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. Elife (2013) 1.03
Protein-RNA and protein-protein recognition by dual KH1/2 domains of the neuronal splicing factor Nova-1. Structure (2011) 1.01
A T-cell receptor associated with naturally occurring human tumor immunity. Proc Natl Acad Sci U S A (2007) 0.96
Cellular immune suppression in paraneoplastic neurologic syndromes targeting intracellular antigens. Arch Neurol (2012) 0.95
The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells. PLoS One (2010) 0.94
Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice. Hum Mol Genet (2013) 0.92
Functional and mechanistic insights from genome-wide studies of splicing regulation in the brain. Adv Exp Med Biol (2007) 0.91
Observing the invisible: successful tumor immunity in humans. Nat Immunol (2003) 0.90
Determination and augmentation of RNA sequence specificity of the Nova K-homology domains. Nucleic Acids Res (2004) 0.90
Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer. PLoS One (2010) 0.88
Sox21 is a repressor of neuronal differentiation and is antagonized by YB-1. Neurosci Lett (2004) 0.86
Tolerance to the neuron-specific paraneoplastic HuD antigen. PLoS One (2009) 0.85
Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo. Elife (2013) 0.85
The neuronal splicing factor Nova controls alternative splicing in N-type and P-type CaV2 calcium channels. Channels (Austin) (2010) 0.82
Characterization of Xenopus Phox2a and Phox2b defines expression domains within the embryonic nervous system and early heart field. Gene Expr Patterns (2004) 0.81
T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation. Eur J Immunol (2014) 0.79
Ri/Nova gene-associated paraneoplastic subacute motor neuronopathy. Muscle Nerve (2013) 0.77
Electronic structure of copper phthalocyanine: an experimental and theoretical study of occupied and unoccupied levels. J Chem Phys (2007) 0.77
NMDA receptor as a target in paraneoplastic encephalitis. Ann Neurol (2007) 0.76
Emission-depth-selective auger photoelectron coincidence spectroscopy. Phys Rev Lett (2005) 0.75
Erratum: Mapping Argonaute and conventional RNA-binding protein interactions with RNA at single-nucleotide resolution using HITS-CLIP and CIMS analysis. Nat Protoc (2016) 0.75
Experimental and theoretical investigation of the pyrrole/Al(100) interface. J Phys Chem A (2009) 0.75
Turkey must end violent response to protests. Science (2013) 0.75
Autoimmune encephalopathy: the spectrum widens. Ann Neurol (2009) 0.75